Total Funding
66
73
Total FundingVenture - Series Unknown raised
Growth Score 66 in past quarter
-3 pts
Heat Score 73 in past quarter
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
38169
CoImmune is a cell therapy company designed to leverage your own immune system to fight disease.
- Charles A. Nicolette: President & CEOPast Role: Genzyme, Director of Antigen Discovery
- Lori Harrelson: Chief Financial OfficerPast Role: Argos Therapeutics, Vice President of Finance
About the Company
CoImmune is a cell therapy company designed to leverage its own immune system to fight disease. It is a clinical-stage immuno-oncology company that will redefine cancer treatment using best-in-class cellular immunotherapies.